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Imidazole-based carbohydrazides, i.e. 3-oxidoimidazole-4-carbohydrazides 1 
and 2-(imidazol-2-yl)sulfanylacetohydrazides 6, react with aryl isoselenocyanates 4 in 
MeOH at room temperature to give the corresponding selenosemicarbazides 5 and 7, 
respectively, in good yields. On heating 7b in DMF in the presence of air to 100°, 1,3,4-
oxadiazole 8a was formed via cyclization and formal elimination of H2Se. Product 8a 
was also obtained after heating of a mixture of 4a and 6b under the same conditions. On 
the other hand, on heating of a solution of 7c in MeOH at reflux, a cyclization to give 
the corresponding 1,2,4-triazole-3-selone 9b occurred. Again, the same product was 
formed when a mixture of 4b and 6b was heated in MeOH. Surprisingly, analogous 
cyclizations of selenosemicarbazides of type 5 under the same conditions failed, and 
only decomposition was observed. The structures of 7a, 7d, and 9b have been 
established by X-ray crystallography. 
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1. Introduction. – Isoselenocyanates are well known as versatile building 
blocks for the preparation of linear and cyclic selenoorganic compounds [1]. It is also 
well documented that many seleninum-containing products display diverse biological 
activities, and some are of significant importance in the pharmaceutical and 
agrochemical fields [2]. In analogy to isocyanates and isothiocyanates, 
isoselenocyanates easily react with N-nucleophiles, such as primary and secondary 
amines, furnishing the corresponding selenoureas [1][3]. Hydrazines display a similar 
reactivity leading to selenosemicarbazides [4]. In the case of carbohydrazides, only a 
few reactions with isoselenocyanates have been reported to date [4a][4b][5]. Whereas, 
to the best of our knowledge, carbohydrazides derived from heterocyclic carboxylic 
acids have not yet been used in such reactions [6], reactions of benzohydrazide with 
aliphatic and aromatic isoselenocyanates are known [4a][4c], and in a recent study, 
selenosemicarbazides obtained thereby were shown to form 1,3,4-oxadiazole derivatives 
upon heating in DMF solution to 100° in the presence of air-oxygen [5]. This reaction 
was accompanied by the formation of elemental Se. Other reactions aimed at the 
synthesis of Se-containing heterocycles starting with selenosemicarbazides have not 
been described. 
 
In a series of recent publications, we reported on the preparation and some reactions of 
imidazole-based carbohydrazides. For example, carbohydrazides of imidazole N-oxides 
1 reacted with isocyanates and isothiocyanates leading to semicarbazides 2 and 
thiosemicarbazides 3, respectively, in good yields [7] (Scheme 1). Both types of 
products were subsequently used as starting materials for the preparation of bis-
heterocyclic systems.  
 
Scheme 1 
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The goal of the present study was the synthesis of new selenosemicarbazides 
derived from imidazole carbohydrazides and their potential application for the 
preparation of Se-containing bis-heterocyclic products. 
 
2. Results and Discussion. – The starting carbohydrazides of type 1 are 
conveniently accessible via cyclocondensation of α-hydroxyimino-β-ketoesters with 
formaldehyde imines and subsequent treatment of the 3-oxidoimidazole-4-carboxylates 
with NH2NH2 . H2O [7b]. Under standard conditions, the hydrazides 1 are stable, 
crystalline materials. The reactions of 1 with arylisoselenocyanates 4 were performed at 
room temperature in MeOH under light protection. In all cases, selenosemicarbazides 5 
were isolated after ca. two days as crystalline materials in good yields (Scheme 2). 
 
Scheme 2 
 
The spectroscopic data confirmed the expected structures. For example, in the 
case of 5a, the characteristic 1H-NMR absorption of H–C(2) was observed at 8.48 ppm, 
indicative for 2-unsubstituted imidazole N-oxides. The CONH group absorbed at 1671 
cm–1 in the IR spectrum, and the corresponding signal in the 13C-NMR spectrum 
appeared at 179.4 ppm. In addition, the C=Se signal was found at 159.9 ppm. The HR-
ESI-MS showed the typical pattern for Se-containing substances with m/z 372.0367. 
These data evidence that the reactions occurred via nucleophilic attack of the hydrazide 
NH2 group on the isoselenocyanate, and the N-oxide function is preserved under the 
reaction conditions. 
In an extension of the study, carbohydrazides of type 6 were used for the 
reactions with 4. These hydrazides were prepared via alkylation of enolizable 
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imidazole-2-thiones with 2-bromoethanoates [8]. The esters obtained thereby were 
converted to the carbohydrazides by standard treatment with excess NH2NH2 . H2O 
[7b]. The reactions of 6 with 4 were also carried out in MeOH at room temperature to 
yield crystalline products in all cases. The structures of the formed 
selenosemicarbazides 7 were proven by the spectroscopic data (Scheme 3). The 1H-
NMR spectra revealed the presence of the SCH2CO fragment by an absorption at 3.95–
3.45 ppm. In analogy to compounds 5, the C=Se and C=O absorptions in the 13C-NMR 
spectra appeared at ca. 180 and 160 ppm, respectively. In the cases of 7a and 7d, single 
crystals suitable for X-ray crystallography were obtained, and the molecular structures 
of these compounds were unambiguously confirmed (Table). 
 
 Scheme 3 
 
Fig. 1. ORTEP Plot  [9] of the molecular structure of 7d (50% probability ellipsoids; 
arbitrary numbering of the atoms) 
 
The molecular structure of 7d is shown in Fig. 1. The asymmetric unit contains a 
single molecule. All three NH groups are involved in H-bonds. H–N(20) forms a weak 
intramolecular H-bond with the unsubstituted N(1)-atom in the five-membered ring. 
This interaction creates a loop which can be described by a graph set motif [10] of 
S(10). H–N(17) forms an intermolecular H-bond with the same acceptor atom (N(1)) in 
an adjacent molecule related to the donor molecule by a centre of inversion. Therefore, 
this interaction links pairs of molecules into dimers and can be described by a graph set 
motif of R2,2(14). H–N(18) forms an intermolecular H-bond with the Se-atom in a 
different adjacent molecule which is also related to the donor molecule by a centre of 
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inversion. This interaction also links pairs of molecules and can be described by a graph 
set motif of R2,2(8). The combination of the intermolecular interactions links the 
molecules into extended chains, which run parallel to the [110] direction. 
The molecular structure of 7a is quite similar to that of 7d, but there are two symmetry-
independent molecules, A and B, of 7a and one disordered molecule of CHCl3 in the 
asymmetric unit.  The space group of 7a is centrosymmetric.  For convenience, the 
asymmetric unit was chosen such that molecule B is related to molecule A by a non-
crystallographic centre of inversion at (0.24, 0.0, 0.25).  The two independent molecules 
have very similar conformations with an r.m.s. fit of 0.084 Å between the non-H atoms 
of molecule A and the inverted atoms of molecule B.  The H-bonding pattern and motifs 
in 7a are the same as those observed in 7d, except that where the intermolecular 
interactions in 7d link molecules across crystallographic centres of inversion to form the 
extended chains, the interactions in 7a link molecules A and B in an alternating fashion 
across non-crystallographic centres of inversion to give extended chains which run 
parallel to the [100] direction. 
Both types of selenosemicarbazides, 5 and 7, are stable at room temperature in 
the crystalline state as well as in solution. Prompted by recently published results [5], 
we selected 7b for the attempted thermal formation of the corresponding 1,3,4-
oxadiazole 8a (Scheme 4). Thus, a solution of 7b in dry DMF was heated to 100° under 
an air atmosphere. After 6 h, the 1H-NMR spectra evidenced the disappearance of the 
starting material and the presence of a new product. The same product was obtained 
when a mixture of 4a and 6b was heated in DMF under air for 6 h3).  
 
                                                          
3) The analogous experiments with 5a and 1a + 4a, respectively, failed, and only 
decomposition and formation of Se was observed. 
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Scheme 4 
 
In order to check whether the formation of Se-containing products from 5 and 7 
is possible, solutions of 5b and 7c in MeOH were heated at reflux. Under these 
conditions, after 4 h, 7c was completely converted into a new compound, which was 
isolated as a crystalline material in 57% yield. The ESI-MS showed the [M+1]+ peak at 
m/z 534, which corresponds with the molecular formula C16H19N5OSSe, differing from 
that of 7c by elimination of H2O. The IR spectrum indicated that the new product does 
not contain a C=O group. The 13C-NMR signal at 160.3 ppm suggested the preservation 
of the selenourea fragment. Based on these data, the structure of 1,2,4-triazole-3-selone 
9b is proposed (Scheme 5)4). The same product was obtained from 6b and 4b in boiling 
MeOH. Finally, crystals of 9b suitable for a crystal-structure determination were 
obtained from MeOH, and the structure of the 1,2,4-thiazole-2-selone 9b was 
established (Fig. 2). 
 
Scheme 5 
 
Fig. 2. ORTEP Plot  [9] of the molecular structure of 9b (50% probability ellipsoids; 
arbitrary numbering of the atoms; the MeOH molecule is not shown) 
 
The asymmetric unit contains one molecule of 9b plus one molecule of MeOH. 
The crystal was of poor quality and produced very broad reflection profiles. 
Consequently, the R-factor remains high and the precision of the geometric parameters 
is low. Nonetheless, the overall structure of the molecule is unambiguous. The space 
                                                          
4) The analogous reactions with 5b failed. 
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group is non-centrosymmetric, but the presence of mirror or glide planes dictates that 
the compound in the crystal is racemic. The absolute structure has been determined by 
the diffraction experiment. The intermolecular H-bonds N(3)–H…O(2’) and O(2)–
H…N(5) link the molecules 9b and the MeOH molecule in an alternating fashion into 
extended chains, which run parallel to the [001] direction and have a graph set motif of 
C2,2(10). 
 
3. Conclusions. – The present study showed that imidazole-based 
carbohydrazides 1 and 6 react smoothly with aromatic isoselenocyanates 4 to yield the 
corresponding selenosemicarbazides 5 and 7, respectively. It is worth mentioning that in 
the case of 1 the N-oxide function is preserved. Upon heating in DMF at 100° in the 
presence of air-oxygen, 7b undergoes a cyclization to give 1,3,4-oxadiazole 8a, whereas 
compounds 5 decompose under these conditions. The same product 8a is formed from 
6b and 4a in DMF under air at 100°. In contrast to thiosemicarbazides [7a], the Se-
analogues 7 undergo cyclization to give 1,2,4-triazole-3-selones 9 under mild thermal 
conditions, and no catalyst is required. To the best of our knowledge, this is the first 
type of cyclization of selenosemicarbazides, which occurs without loss of Se. 
 
The authors thank PD Dr. L. Bigler, University of Zurich, for recording of the 
HR-ESI-MS spectra. A. M. P. is grateful for financial support within the project co-
funded by the European Union under the European Social Fund ‘HUMAN – BEST 
INVESTMENT!’  
 
Experimental Part 
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1. General. M.p.: Melt-Temp. II (Aldrich) or STUART SMP30; uncorrected. IR 
Spectra: NEXUS FT-IR spectrophotometer; in KBr; absorptions in cm–1. 1H- and 
13C{1H}-NMR spectra: Bruker Avance III (600 and 150 MHz, resp.), using solvent 
signal as reference; δ in ppm; coupling constants J in Hz; assignments of signals in  
13C-NMR spectra accomplished by HMQC experiments. HR-ESI-MS: Bruker maXis 
spectrometer.  
 2. Starting Materials. All solvents are commercially available and were used as 
received. Carbohydrazides 1a and 1b were prepared from the corresponding esters by 
treatment with NH2NH2·H2O according to the protocol described in [7b].  
 3. Synthesis of Selenosemicarbazides 5a – 5d and 7a – 7g. General Procedure. 
A mixture of 1 or 6 (1 mmol) and the corresponding isoselenocyanate 4 (1.1 mmol) in 
MeOH (5 ml) was stirred for 48 h. Then, the product formed was filtered off, washed 
with MeOH, and crystallized from an acetone/MeOH mixture (1:1).  
 1-{[(1,5-Dimethyl-3-oxido-1H-imidazol-4-yl)carbonyl]amino}-3-(4-fluoro-
phenyl)selenourea (5a). Yield: 0.326 g (88%). Colorless crystals. M.p. 198–200° 
(MeOH). IR (KBr): 3154s (NH), 3054m, 2934m, 1671vs (C=O), 1636vs, 1597s, 1510s, 
1463s, 1227m. 1H-NMR ((D6)DMSO): 10.13 (br. s, NH); 8.48 (s, HC(2)); 7.41–7.13 (m, 
4 arom. H); 3.59 (s, MeN); 2.49 (s, Me). 13C-NMR ((D6)DMSO): 179.4 (C=O); 159.9 
(C=Se); 149.5, 137.8, 132.0, 120.5 (2 arom. C, C(4), C(5)); 129.2, 115.0 (4 arom. CH); 
126.9 (C(2)); 32.4 (MeN); 9.5 (MeC(5)). HR-ESI-MS: 372.0367 ([M + H]+, 
C13H15FN5O2Se+; calc. 372.03698).  
 1-{[(1,5-Dimethyl-3-oxido-1H-imidazol-4-yl)carbonyl]amino}-3-(4-methoxy-
phenyl)selenourea (5b). Yield: 0.272 g (71%). Colorless crystals. M.p. 175–176° 
(MeOH). IR (KBr): 3157s (NH), 2933m, 1671vs (C=O), 1637vs, 1601s, 1512s, 1459s, 
1255m. 1H-NMR ((D6)DMSO): 10.02 (br. s, NH); 8.48 (s, HC(2)); 7.27, 6.88 (AA’BB’, 
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JAB = 7.6, 4 arom. H); 3.75 (s, MeO); 3.59 (s, MeN); 2.49 (s, Me). 13C-NMR 
((D6)DMSO): 179.7 (C=O); 159.9 (C=Se); 155.0, 137.4, 131.8, 119.1 (2 arom. C, C(4), 
C(5)); 128.4, 114.8 (4 arom. CH); 126.8 (C(2)); 55.7 (MeO); 32.4 (MeN); 9.5 (MeC(5)). 
HR-ESI-MS: 384.0567 ([M + H]+, C14H18N5O3Se+; calc. 384.05698).  
 1-{[(1-Benzyl-5-methyl-3-oxido-1H-imidazol-4-yl)carbonyl]amino}-3-(4-fluoro-
phenyl)selenourea (5c). Yield: 0.381 g (85%). Colorless crystals. M.p. 180–181° 
(MeOH). IR (KBr): 3127s (NH), 3061m, 1667vs (C=O), 1598s, 1508s, 1481s, 1215m. 
1H-NMR ((D6)DMSO): 10.17, 10.10 (2br. s, NH); 8.74 (s, HC(2)); 7.43–7.13 (m, 9 
arom. H); 5.26 (s, CH2); 2.45 (s, Me). 13C-NMR ((D6)DMSO): 180.0 (C=O); 164.7 
(C=Se); 143.5, 139.9, 135.8, 131.4, 119.3 (3 arom. C, C(4), C(5)); 126.8 (C(2)); 129.5, 
128.7, 127.8, 127.1, 116.2 (9 arom. CH); 48.8 (CH2); 9.8 (Me). HR-ESI-MS: 448.0681 
([M + H]+, C19H19FN5O2Se+; calc. 448.0683).  
 1-{[(1-Benzyl-5-methyl-3-oxido-1H-imidazol-4-yl)carbonyl]amino}-3-
phenylselenourea (5d). Yield: 0.270 g (63%). Colorless crystals. M.p. 192–193° 
(MeOH). IR (KBr): 3216m, 3127s (NH), 3044m, 1667vs (C=O), 1597s, 1479s, 1328m. 
1H-NMR ((D6)DMSO): 10.13 (br. s, NH); 8.72 (s, HC(2)); 7.41–7.17 (m, 10 arom. H); 
5.26 (s, CH2); 2.45 (s, Me). 13C-NMR ((D6)DMSO): 179.6 (C=O); 159.8 (C=Se); 139.9, 
135.8, 131.4, 121.9 (2 arom. C, C(4), C(5)); 126.8 (C(2)); 129.5, 128.7, 128.6, 127.7, 
127.6, 126.3 (10 arom. CH); 48.8 (CH2); 9.8 (Me). HR-ESI-MS: 430.0774 ([M + H]+, 
C19H20N5O2Se+; calc. 430.0777).  
 1-(4-Methoxyphenyl)-3-{[2-(1,4,5-trimethylimidazol-2-yl)sulfanylacetyl] 
amino}selenourea (7a). Yield: 0.246 g (58%). Colorless crystals. M.p. 132–134° 
(MeOH). IR (KBr): 3273m, 3124m (NH), 2943m, 1692s (C=O), 1540s, 1512vs, 1246m. 
1H-NMR ((D6)DMSO): 10.31 (br. s, NH); 9.98 (br. s, NH); 7.21, 6.88 (AA’BB’, JAB = 
7.6, 4 arom. H); 3.75 (s, MeO); 3.52 (s, CH2); 3.48 (s, MeN); 2.04, 1.67 (2s, 2 Me). 13C-
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NMR ((D6)DMSO): 179.8 (C=O); 164.8 (C=Se); 157.8, 136.3, 133.7, 126.3, 119.1 (2 
arom. C, C(2), C(4), C(5)); 128.8, 114.8 (4 arom. CH); 55.7 (MeO); 36.8 (CH2); 31.5 
(MeN); 12.4, 9.2 (2 Me). HR-ESI-MS: 428.0654 ([M + H]+, C16H22N5O2SSe+; calc. 
428.0654).  
 1-(4-Fluorophenyl)-3-{[2-(1-methyl-4,5-diphenylimidazol-2-yl)sulfanyl-
acetyl]amino}selenourea (7b). Yield: 0.323 g (60%). Colorless crystals. M.p. 143–144° 
(MeOH). IR (KBr): 3289s, 3214s (NH), 2976m, 1686s (C=O), 1530vs, 1506vs, 1208m. 
1H-NMR ((D6)DMSO): 10.48 (br. s, NH); 10.19 (br. s, NH); 9.95 (br. s, NH); 7.34–7.07 
(m, 14 arom. H); 3.95 (s, CH2); 3.40 (s, MeN). 13C-NMR ((D6)DMSO): 167.8 (C=O); 
160.7 (C=Se); 157.6, 141.1, 137.8, 131.4, 126.5, 119.1 (4 arom. C, C(2), C(4), C(5)); 
131.0, 130.7, 129.6, 129.4, 129.2, 128.5, 126.5, 115.1 (14 arom. CH); 36.0 (CH2); 32.2 
(MeN). HR-ESI-MS: 540.0763 ([M + H]+, C25H23FN5OSSe+; calc. 540.0768).  
 1-(4-Methoxyphenyl)-3-{[2-(1-methyl-4,5-diphenylimidazol-2-yl)sulfanyl-
acetyl]amino}selenourea (7c). Yield: 0.336 g (61%). Colorless crystals. M.p. 175–176° 
(MeOH). IR (KBr): 3370s, 3208s (NH), 2953m, 1690s (C=O), 1541vs, 1510s, 1244m. 
1H-NMR ((D6)DMSO): 10.47 (br. s, NH); 10.07 (br. s, NH); 9.87 (br. s, NH); 7.52–6.82 
(m, 14 arom. H); 3.94 (s, CH2); 3.74 (s, MeO); 3.40 (s, MeN). 13C-NMR ((D6)DMSO): 
165.3 (C=O); 162.6 (C=Se); 157.7, 141.7, 137.7, 131.4, 126.5, 113.6 (4 arom. C, C(2), 
C(4), C(5)); 134.5, 131.0, 130.6, 129.6, 129.4, 128.5, 128.4, 126.8 (14 arom. CH); 55.7 
(MeO); 36.1 (CH2); 32.2 (MeN). HR-ESI-MS: 552.0965 ([M + H]+, C26H26N5O2SSe+; 
calc. 552.0968).  
 1-(4-Methoxyphenyl)-3-{[2-(1,5-dimethyl-4-phenylimidazol-2-yl)sulfanyl-
acetyl]amino}selenourea (7d). Yield: 0.312 g (64%). Colorless crystals. M.p. 169–
171°C (MeOH). IR (KBr): 3301s, 3154s (NH), 2947m, 1697vs (C=O), 1530s, 1512s, 
1245m. 1H-NMR ((D6)DMSO): 10.36 (br. s, NH); 10.01 (br. s, NH); 9.90 (br. s, NH); 
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7.35–6.81 (m, 9 arom. H); 3.77 (s, CH2); 3.73 (s, MeO); 3.57 (s, MeN); 2.33 (s, Me). 
13C-NMR ((D6)DMSO): 179.7 (C=O); 167.9 (C=Se); 157.7, 138.9, 137.5, 135.2, 132.9, 
126.5 (3 arom. C, C(2), C(4), C(5)); 128.7, 128.5, 127.2, 127.0, 113.6 (9 arom. CH); 
55.7 (MeO); 36.6 (CH2); 31.5 (MeN); 10.7 (Me). HR-ESI-MS: 490.0810 ([M + H]+, 
C21H24N5O2SSe+; calc. 490.0811).  
 1-(4-Fluorophenyl)-3-{[2-(1,5-dimethyl-4-phenylimidazol-2-yl)sulfanyl-
acetyl]amino}selenourea (7e). Yield: 0.400 g (83%). Colorless crystals. M.p. 172–173° 
(MeOH). IR (KBr): 3256s (NH), 3055m, 1686vs (C=O), 1541s, 1508s, 1212m. 1H-
NMR ((D6)DMSO): 10.00 (br. s, NH); 7.50–6.65 (m, 9 arom. H); 3.70 (s, CH2); 3.60 (s, 
MeN); 2.30 (s, Me).  
 1-{[2-(1-Benzyl-4,5-dimethyl-imidazol-2-yl)sulfanylacetyl]amino}-3-(4-
fluorophenyl)selenourea (7f). Yield: 0.370 g (75%). Colorless crystals. M.p. 158–160° 
(MeOH). IR (KBr): 3330m, 3126m (NH), 3030m, 1698vs (C=O), 1552s, 1508s, 1215m. 
1H-NMR ((D6)DMSO): 10.65 (br. s, NH); 7.60–6.80 (m, 9 arom. H); 5.20 (s, PhCH2); 
3.45 (s, SCH2); 2.00, 1.75 (2s, 2 Me).  
 1-{[2-(1-Benzyl-4,5-dimethylimidazol-2-yl)sulfanylacetyl]amino}-3-(4- 
methoxyphenyl)selenourea (7g). Yield: 0.430 g (86%). Colorless crystals. M.p. 142–
144° (MeOH). IR (KBr): 3165m, 3127m (NH), 2955m, 1696vs (C=O), 1510s, 1455m, 
1243m. 1H-NMR ((D6)DMSO): 9.80 (br. s, NH); 8.30 (br. s, NH); 7.50–6.75 (m, 9 
arom. H); 5.05 (s, PhCH2); 3.75 (s, MeO); 3.50 (s, SCH2); 1.95, 1.90 (2s, 2 Me).  
 4. General Procedure for the Synthesis of Hydrazides 6 [8]. To a soln. of a 1H-
imidazole-2-thione (1 mmol) in CH2Cl2 (5 ml) was added methyl 2-bromoacetate (1 
mmol). The mixture was stirred for 48 h at r.t., then, the solvent was evaporated i.v., and 
the residue was used immediately without further purification. The oily residue was 
dissolved in EtOH (5 ml), and NH2NH2·H2O (2 mmol) was added. The mixture was 
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heated at reflux for 4 h, the solvent was evaporated i.v., and the residue was crystallized 
from MeOH.  
 2-[(1,4,5-Trimethylimidazol-2-yl)sulfanyl]acetohydrazide (6a). Yield: 0.208 g 
(97%). Colorless crystals. M.p. 135–136° (MeOH). IR (KBr): 3336m, 3285m (NH), 
2941m, 1683s (C=O), 1551s, 1436vs, 1229m. 1H-NMR ((D6)DMSO): 9.88 (br. s, NH); 
3.59 (s, CH2); 3.43 (s, MeN); 2.14, 2.11 (2s, 2 Me). 13C-NMR ((D6)DMSO): 170.3 
(C=O); 138.1, 134.0, 125.3 (C(2), C(4), C(5)); 35.0 (CH2); 30.8 (MeN); 12.7, 9.0 (2 
Me). HR-ESI-MS: 215.0961 ([M + H]+, C8H15N4OS+; calc. 215.0961).  
 2-[(1-Methyl-4,5-diphenylimidazol-2-yl)sulfanyl]acetohydrazide (6b). Yield: 
0.311 g (92%). Colorless oil. IR (KBr): 3316m (NH), 2944m, 1672vs (C=O), 1602s, 
1503s, 1320m. 1H-NMR ((D6)DMSO): 9.99 (br. s, NH); 7.48–7.15 (m, 10 arom. H); 
3.83 (s, CH2); 3.37 (s, MeN). 13C-NMR ((D6)DMSO): 170.2 (C=O); 142.1, 137.9, 
133.6, 131.0, 126.4 (2 arom. C, C(2), C(4), C(5)); 130.7, 130.1, 129.2, 129.0, 128.3, 
126.8 (10 arom. CH); 34.3 (CH2); 31.6 (MeN). HR-ESI-MS: 339.1272 ([M + H]+, 
C18H19N4OS+; calc. 339.1274).  
 2-[(1,5-Dimethyl-4-phenylimidazol-2-yl)sulfanyl]acetohydrazide (6c). Yield: 
0.207 g (75%). Colorless crystals. M.p. 112–113° (MeOH). IR (KBr): 3301m, 3218m 
(NH), 2980m, 1697vs (C=O), 1661s. 1H-NMR ((D6)DMSO): 9.33 (br. s, NH); 7.58–
7.22 (m, 5 arom. H); 3.63 (s, CH2); 3.54 (s, MeN); 2.36 (s, Me). 13C-NMR 
((D6)DMSO): 167.6 (C=O); 138.8, 137.4, 135.5, 126.5 (1 arom. C, C(2), C(4), C(5)); 
128.8, 127.2, 126.9 (5 arom. CH); 36.4 (CH2); 31.4 (MeN); 10.9 (Me). HR-ESI-MS: 
277.1118 ([M + H]+, C13H17N4OS+; calc. 277.1118).  
 2-[(1-Benzyl-4,5-dimethylimidazol-2-yl)sulfanyl]acetohydrazide (6d). Yield: 
0.258 g (89%). Colorless crystals. M.p. 131–132° (MeOH). IR (KBr): 3321m, 3223m 
(NH), 2969m, 1671vs (C=O), 1542s, 1496s, 1421m. 1H-NMR (CDCl3): 9.90 (br. s, 
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NH); 7.45–6.85 (m, 5 arom. H); 5.05 (s, PhCH2); 3.80 (br. s, NH2); 3.50 (s, SCH2); 2.15, 
2.00 (2s, 2 Me).  
 5. Synthesis of 8a. Procedure A. A mixture of 6b (1 mmol) and 4a (1.1 mmol) in 
DMF (10 ml) was heated to 100° for 6 h under air atmosphere. The black Se powder 
was filtered off and washed with CH2Cl2 (10 ml). The combined filtrate was 
concentrated i.v., and the residue was crystallized from acetone/MeOH (1:1).  
Procedure B. Selenosemicarbazide 7b (1 mmol) in DMF (10 ml) was heated to 100° for 
6 h under air atmosphere, and the mixture was worked up as described in Procedure A. 
 N-(4-Fluorophenyl)-5-{[(1-methyl-4,5-diphenylimidazol-2-yl)sulfanyl]methyl}-
1,3,4-oxadiazol-2-amine (8a). Yield: 0.330 g (72%, Procedure A); 0.321 g (70%, 
Procedure B). Colorless crystals. M.p. 123–124° (MeOH). IR (KBr): 3224s (NH), 
2996m, 1504vs, 1238m. 1H-NMR ((D6)DMSO): 10.44 (br. s, NH); 7.57–7.10 (m, 14 
arom. H); 4.51 (s, CH2); 3.31 (s, MeN). 13C-NMR ((D6)DMSO): 181.9, 160.7, 157.6, 
138.5, 131.2, 126.5, 119.1 (oxadiazol C(2), C(5), 4 arom. C, imidazole C(2’), C(4’), 
C(5’)); 130.9, 129.7, 129.6, 129.4, 129.0, 128.5, 126.9, 116.0 (14 arom. CH); 36.3 
(CH2); 32.2 (MeN). HR-ESI-MS: 458.1448 ([M + H]+, C25H21FN5OS+; calc. 458.1445).  
 6. Synthesis of 1H-1,2,4-Triazole-5-selones 9a – 9d. Procedure A. A mixture of 
6 (1 mmol) and the corresponding isoselenocyanate 4 (1.1 mmol) in MeOH (10 ml) was 
heated at reflux for 4 h under N2 atmosphere. Then, the product formed was filtered off, 
washed with MeOH, and crystallized from acetone/MeOH (1:1). Procedure B. 
Selenosemicarbazide 7 (1 mmol) in MeOH (10 ml) was heated at reflux for 4 h under 
N2 atmosphere. Then, the mixture was worked up as described in Procedure A. 
  4-(4-Methoxyphenyl)-3-{[(1,4,5-trimethylimidazol-2-yl)sulfanyl]methyl}-1H-
1,2,4-triazole-5-selone (9a). Yield: 0.260 g (64%, Procedure A). Colorless crystals. 
M.p. 190–191° (MeOH). IR (KBr): 3006m, 2917m, 2881m, 1515s, 1465s, 1251m, 
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1171m. 1H-NMR ((D6)DMSO): 7.45–6.70 (m, 4 arom. H); 3.95 (s, CH2); 3.85 (s, MeO); 
3.30 (s, MeN); 2.05  (s, 2 Me). ESI-MS: 410 ([M + H]+); 432 ([M + Na]+); 448 ([M + 
K]+).  
 4-(4-Methoxyphenyl)-3-{[(1-methyl-4,5-diphenylimidazol-2-yl)sulfanyl]methyl}-
1H-1,2,4-triazole-5-selone (9b). Yield: 0.301 g (57%), Procedure A); 0.317 g (60%), 
Procedure B). Colorless crystals. M.p. 133–135° (MeOH). IR (KBr): 3057m, 2928m, 
1515s, 1454s, 1253m. 1H-NMR ((D6)DMSO): 14.20 (br. s, NH); 7.65–6.80 (m, 14 arom. 
H); 4.25 (s, CH2); 3.75 (s, MeO); 3.30 (s, MeN). 13C-NMR ((D6)DMSO): 160.3 (C=Se); 
157.8, 155.6, 150.1, 134.7, 131.4, 131.0, 130.9, 126.5 (triazol C(2), 4 arom. C, imidazol 
C(2’), C(4’), C(5’)); 129.6, 129.3, 128.5, 126.8, 126.6, 124.4, 119.1, 114.8 (14 arom. 
CH); 55.5 (MeO); 49.1 (MeN); 32.2 (CH2). HR-ESI-MS: 534.0859 ([M + H]+, 
C26H24N5OSSe+; calc. 534.0862).  
 3-{[(1-Benzyl-4,5-dimethylimidazol-2-yl)sulfanyl]methyl}-4-(4-methoxyphenyl)-
1H-1,2,4-triazole-5-selone (9c). Yield: 0.410 g (86%, Procedure B). Colorless crystals. 
M.p. 164–167° (MeOH). IR (KBr): 3066m, 2923m, 2857m, 1514s, 1254m, 1180m. 1H-
NMR (CDCl3): 11.10 (br. s, NH); 7.35–6.70 (m, 9 arom. H); 5.05 (s, PhCH2); 3.80 (s, 
MeO); 3.75 (s, SCH2); 2.25, 1.95  (2s, 2 Me).   
 4-(4-Fluorophenyl)-3-{[(1,4,5-trimethylimidazol-2-yl)sulfanyl]methyl}-1H-
1,2,4-triazole-5-selone (9d). Yield: 0.104 g (25%, Procedure A). Colorless crystals. 
M.p. 154–155° (MeOH). IR (KBr): 3181m (NH), 3033m, 2893m, 1540s, 1508vs, 
1227m. 1H-NMR ((D6)DMSO): 14.34 (br. s, NH); 7.45–7.38 (m, 4 arom. H); 4.02 (s, 
CH2); 3.28 (s, MeN); 2.04, 1.97 (2s, 2 Me). 13C-NMR ((D6)DMSO): 163.6 (C=Se); 
161.9, 151.3, 134.3, 133.9, 130.6, 126.7 (triazol C(2), 2 arom. C, imidazol C(2’), C(4’), 
C(5’)); 131.2, 116.6 (4 arom. CH); 31.1 (MeN); 28.9 (CH2); 13.0, 9.3 (2 Me). HR-ESI-
MS: 398.0349 ([M + H]+, C15H17FN5SSe+; calc. 398.0348).  
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7. X-Ray Crystal-Structure Determination of 7a, 7d, and 9b (Table and Figs. 1 
and 2)5). All measurements were performed on a Nonius KappaCCD diffractometer [11] 
using graphite-monochromated MoKα radiation (λ 0.71073 Å) and an Oxford 
Cryosystems Cryostream 700 cooler. The data collection and refinement parameters are 
given in the Table, and views of the molecules 7d and 9b are shown in Figs. 1 and 2, 
respectively. Data reduction was performed with HKL Denzo and Scalepack [12]. The 
intensities were corrected for Lorentz and polarization effects, and an absorption 
correction based on the multi-scan method [13] was applied. Equivalent reflections, 
other than Friedel pairs in 9b, were merged. The structures were solved by direct 
methods using SIR92 [14], which revealed the positions of all non-H-atoms. In the case 
of 7a, the asymmetric unit contains two symmetry-independent molecules 7a and one 
disordered molecule of CHCl3. The solvent molecule could not be modelled 
satisfactorily, so the SQUEEZE routine [15] of the program PLATON [16] was 
employed. This procedure, which allows the disordered solvent molecules to be omitted 
entirely from the subsequent refinement model, gave better refinement results and there 
were no significant peaks of residual electron density to be found in the voids of the 
structure. The procedure leaves one cavity of 303 Å3 per unit cell.  The electron count in 
the disordered region was calculated to be 80 e per cavity. One molecule of CHCl3 per 
cavity corresponded with the peaks of residual electron density observed prior to the 
application of the SQUEEZE procedure. This yields 58 e and this estimate was used in 
the subsequent calculation of the empirical formula, formula weight, density, linear 
absorption coefficient and F(000). In all cases, the non-H-atoms were refined 
                                                          
5) CCDC-911592–911594 contain the supplementary crystallographic data for this 
paper. These data can be obtained free of charge from the Cambridge 
Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/data_request/cif. 
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anisotropically. In the case of 9b, the poor quality of the crystal and the subsequent data 
meant that it was necessary to restrain atom C(15) to have pseudo-isotropic 
displacement parameters. For 7a and 7d, the H-atoms of the NH groups were placed in 
the positions indicated by a difference electron density map and their positions were 
allowed to refine together with individual isotropic displacement parameters. All 
remaining H-atoms and all H-atoms of 9b were placed in geometrically calculated 
positions and refined using a riding model where each H-atom was assigned a fixed 
isotropic displacement parameter with a value equal to 1.2 Ueq of its parent atom (1.5 
Ueq for Me groups). The refinement of each structure was carried out on F2 using full-
matrix least-squares procedures, which minimized the function Σw(Fo2 – Fc2)2. In the 
cases of 7a and 9b, a correction for secondary extinction was applied, and one reflection 
of 7a, whose intensitiy was considered to be an extreme outlier, was omitted from the 
final refinement. For 9b, refinement of the absolute structure parameter [17] yielded a 
value of –0.02(3), which confidently confirms that the refined model corresponds with 
the true absolute structure. Neutral atom scattering factors for non-H-atoms were taken 
from [18a], and the scattering factors for H-atoms were taken from [19]. Anomalous 
dispersion effects were included in Fc [20]; the values for f ' and f " were those of [18b]. 
The values of the mass attenuation coefficients are those of [18c]. All calculations were 
performed using the SHELXL97 [21] program. 
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Legends 
 
Table. Crystallographic Data for Compounds 7a, 7d, and 9b 
 
 
Fig. 1. ORTEP Plot  [9] of the molecular structure of 7d (50% probability ellipsoids; 
arbitrary numbering of the atoms; the MeOH molecule is not shown) 
 
Fig. 2. ORTEP Plot  [9] of the molecular structure of 9b (50% probability ellipsoids; 
arbitrary numbering of the atoms; solvent molecules omitted) 
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Table.  Crystallographic Data for Compounds 7a, 7d, and 9b 
__________________________________________________________________________________ 
  
 7a 7d 
__________________________________________________________________________________ 
Crystallized from CHCl3 Acetone/EtOH 
Empirical formula C16H21N5O2SSe.0.5CHCl3 C21H23N5O2SSe  
Formula weight [g mol-1] 486.02 488.40  
Crystal color, habit colorless, prism colorless, prism  
Crystal dimensions [mm] 0.20 × 0.25 × 0.30 0.15 × 0.17 × 0.20  
Temperature [K] 160(1) 160(1)  
Crystal system triclinic triclinic  
Space group P
_
,1 P
_
,1  
Z 4 2 
Reflections for cell determination 61134 19838  
2θ range for cell determination [°] 4 – 55 4 – 60  
Unit cell parameters a [Å] 10.3983(2) 9.5183(2)  
 b [Å] 12.7273(2) 9.7896(2)  
 c [Å] 15.9518(2) 12.7504(2) 
 α [°] 84.0962(9) 95.948(1)  
 β [°] 88.1341(9) 98.419(1) 
 γ [°] 82.6491(7) 114.092(1)  
 V [Å3] 2082.24(6) 1055.20(4)  
Dx [g cm-3] 1.550 1.537  
µ(MoKα) [mm-1] 2.117 1.906  
Scan type φ and ω φ and ω  
2θ(max) [°] 55 60  
Transmission factors (min; max) 0.610; 0.686 0.585; 0.756  
Total reflections measured 47740 30512  
Symmetry independent reflections 9492 6143  
Reflections with I > 2σ(I) 7535 5412  
Reflections used in refinement 9491 6143  
Parameters refined; restraints 485; 0 283; 0  
Final R(F) [I > 2σ(I) reflections] 0.0435 0.0617  
 wR(F2) (all data) 0.1090 0.1739  
Weighting parameters [a; b]a)  0.0631; 0 0.1216; 0.7324  
Goodness of fit 1.070 1.075  
Secondary extinction coefficient 0.0148(8) -  
Final ∆max/σ 0.003 0.001 
∆ρ (max; min) [e Å-3] 0.63; –0.52 1.65; –0.74 
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a) w–1 = σ2(Fo2) + (aP)2 + bP where P = (Fo2 + 2Fc2)/3 
 
Table.  Crystallographic Data for Compounds 7a, 7d, and 9b (continued) 
__________________________________________________________________________________ 
  
 9b 
__________________________________________________________________________________ 
Crystallized from MeOH 
Empirical formula C26H23N5OSSe.CH3OH 
Formula weight [g mol-1] 564.50  
Crystal color, habit colorless, plate  
Crystal dimensions [mm] 0.05 × 0.12 × 0.25 
Temperature [K] 160(1) 
Crystal system ortorhombic 
Space group Pna21  
Z 4 
Reflections for cell determination 49048  
2θ range for cell determination [°] 4 – 50  
Unit cell parameters a [Å] 8.174(1)  
 b [Å] 46.768(7)  
 c [Å] 6.943(1) 
 α [°] 90  
 β [°] 90 
 γ [°] 90  
 V [Å3] 2653.8(7)  
Dx [g cm-3] 1.413  
µ(MoKα) [mm-1] 1.526  
Scan type φ and ω  
2θ(max) [°] 50 
Transmission factors (min; max) 0.625; 0.934  
Total reflections measured 11242  
Symmetry independent reflections 4008  
Reflections with I > 2σ(I) 2548  
Reflections used in refinement 4008  
Parameters refined; restraints 329; 7  
Final R(F) [I > 2σ(I) reflections] 0.0876  
 wR(F2) (all data) 0.2268  
 23 
Weighting parameters [a; b]a)  0.0825; 11.7070  
Goodness of fit 1.152  
Secondary extinction coefficient 0.027(2) 
Final ∆max/σ 0.001 
∆ρ (max; min) [e Å-3] 1.02; –0.92 
 
a) w–1 = σ2(Fo2) + (aP)2 + bP where P = (Fo2 + 2Fc2)/3 
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Scheme 3 
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Scheme 5 
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Figure 1 
 
 
 
 
Figure 2 
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